Kay Childs

2.2k total citations · 1 hit paper
18 papers, 1.8k citations indexed

About

Kay Childs is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Kay Childs has authored 18 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Immunology and 6 papers in Epidemiology. Recurrent topics in Kay Childs's work include interferon and immune responses (8 papers), Virology and Viral Diseases (5 papers) and Viral Infections and Vectors (5 papers). Kay Childs is often cited by papers focused on interferon and immune responses (8 papers), Virology and Viral Diseases (5 papers) and Viral Infections and Vectors (5 papers). Kay Childs collaborates with scholars based in United Kingdom, Australia and United States. Kay Childs's co-authors include Stephen Goodbourn, Richard E. Randall, J. Andrejeva, Nicola Stock, D. F. Young, T. S. Carlos, Michael A. Skinner, Craig S. Ross, Louise Hilton and B. Precious and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and SHILAP Revista de lepidopterología.

In The Last Decade

Kay Childs

17 papers receiving 1.8k citations

Hit Papers

The V proteins of paramyxoviruses bind the IFN-inducible ... 2004 2026 2011 2018 2004 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kay Childs United Kingdom 12 1.2k 737 642 487 190 18 1.8k
Gijs A. Versteeg Austria 18 1.4k 1.2× 538 0.7× 536 0.8× 835 1.7× 224 1.2× 33 2.1k
Junji Xing China 21 1.0k 0.9× 543 0.7× 443 0.7× 616 1.3× 195 1.0× 44 1.6k
Chenhe Su China 22 822 0.7× 635 0.9× 350 0.5× 488 1.0× 174 0.9× 27 1.4k
Choon Ping Tan United Kingdom 13 2.2k 1.9× 893 1.2× 620 1.0× 1.2k 2.5× 267 1.4× 14 3.1k
Delphine Goubau United Kingdom 12 2.2k 1.9× 464 0.6× 474 0.7× 1.0k 2.1× 313 1.6× 13 2.7k
Jana M. Ellegast United States 9 1.6k 1.4× 435 0.6× 370 0.6× 1.1k 2.2× 261 1.4× 18 2.3k
Olivier Moncorgé France 17 668 0.6× 680 0.9× 484 0.8× 599 1.2× 64 0.3× 26 1.6k
Takashi Natsukawa Japan 6 2.7k 2.3× 703 1.0× 534 0.8× 1.1k 2.3× 387 2.0× 8 3.2k
Theresa A. Banks United States 19 1.2k 1.0× 581 0.8× 238 0.4× 292 0.6× 223 1.2× 25 1.8k
Maria Kalamvoki United States 21 543 0.5× 594 0.8× 328 0.5× 591 1.2× 95 0.5× 39 1.2k

Countries citing papers authored by Kay Childs

Since Specialization
Citations

This map shows the geographic impact of Kay Childs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay Childs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay Childs more than expected).

Fields of papers citing papers by Kay Childs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kay Childs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay Childs. The network helps show where Kay Childs may publish in the future.

Co-authorship network of co-authors of Kay Childs

This figure shows the co-authorship network connecting the top 25 collaborators of Kay Childs. A scholar is included among the top collaborators of Kay Childs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay Childs. Kay Childs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Childs, Kay, et al.. (2023). Development of a quadrivalent foot-and-mouth disease vaccine candidate for use in East Africa. Vaccine. 41(44). 6572–6578. 2 indexed citations
3.
Jackson, Ben, Kay Childs, Nanchaya Wanasen, et al.. (2022). Analysis of porcine bone marrow-derived macrophage cytokine responses to infection with PRRSV-1 strains of differing virulence. SHILAP Revista de lepidopterología. 2.
4.
Childs, Kay, et al.. (2022). Trans-Encapsidation of Foot-and-Mouth Disease Virus Genomes Facilitates Escape from Neutralizing Antibodies. Viruses. 14(6). 1161–1161. 5 indexed citations
5.
Jackson, Ben, B. Veronica Carr, Kay Childs, et al.. (2022). An Improved αvβ6-Receptor-Expressing Suspension Cell Line for Foot-and-Mouth Disease Vaccine Production. Viruses. 14(3). 621–621. 6 indexed citations
6.
Childs, Kay, Nicholas Juleff, Katy Moffat, & Julian Seago. (2021). Demonstration of Co-Infection and Trans-Encapsidation of Viral RNA In Vitro Using Epitope-Tagged Foot-and-Mouth Disease Viruses. Viruses. 13(12). 2433–2433. 2 indexed citations
7.
Jackson, Ben, Kay Childs, Mark Boyce, et al.. (2021). Rotavirus NSP1 Inhibits Type I and Type III Interferon Induction. Viruses. 13(4). 589–589. 16 indexed citations
8.
Ahmed, Saleem, Musharraf Jelani, Kay Childs, et al.. (2018). A missense mutation in TRAPPC6A leads to build-up of the protein, in patients with a neurodevelopmental syndrome and dysmorphic features. Scientific Reports. 8(1). 2053–2053. 26 indexed citations
9.
Childs, Kay, Richard E. Randall, & Stephen Goodbourn. (2013). LGP2 Plays a Critical Role in Sensitizing mda-5 to Activation by Double-Stranded RNA. PLoS ONE. 8(5). e64202–e64202. 77 indexed citations
10.
Childs, Kay, Richard E. Randall, & Stephen Goodbourn. (2012). Paramyxovirus V Proteins Interact with the RNA Helicase LGP2 To Inhibit RIG-I-Dependent Interferon Induction. Journal of Virology. 86(7). 3411–3421. 116 indexed citations
12.
Childs, Kay, J. Andrejeva, Richard E. Randall, & Stephen Goodbourn. (2008). Mechanism of mda-5 Inhibition by Paramyxovirus V Proteins. Journal of Virology. 83(3). 1465–1473. 112 indexed citations
13.
Stock, Nicola, B. Precious, Kay Childs, et al.. (2007). Mapuera virus, a rubulavirus that inhibits interferon signalling in a wide variety of mammalian cells without degrading STATs. Journal of General Virology. 88(3). 956–966. 25 indexed citations
14.
Childs, Kay, Nicola Stock, Craig S. Ross, et al.. (2006). mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology. 359(1). 190–200. 256 indexed citations
15.
Precious, B., et al.. (2005). Simian Virus 5 V Protein Acts as an Adaptor, Linking DDB1 to STAT2, To Facilitate the Ubiquitination of STAT1. Journal of Virology. 79(21). 13434–13441. 99 indexed citations
16.
Andrejeva, J., Kay Childs, D. F. Young, et al.. (2004). The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN -β promoter. Proceedings of the National Academy of Sciences. 101(49). 17264–17269. 825 indexed citations breakdown →
17.
Marriott, J B, Ian Clarke, Anna Czajka, et al.. (2003). A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins.. PubMed. 63(3). 593–9. 45 indexed citations
18.
Childs, Kay. (2003). Identification of novel co-repressor molecules for Interferon Regulatory Factor-2. Nucleic Acids Research. 31(12). 3016–3026. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026